SVIP and head and neck cancer: In a study that aimed to identify putative genetic and epigenetic changes in the p97/VCP-mediated ERAD pathway in human tumors, SVIP promoter CpG island was found to be methylated in 50% (19 of 38) of head and neck cancer cell lines.